0001209191-22-044894.txt : 20220808 0001209191-22-044894.hdr.sgml : 20220808 20220808193312 ACCESSION NUMBER: 0001209191-22-044894 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220804 FILED AS OF DATE: 20220808 DATE AS OF CHANGE: 20220808 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KANAYA SUSAN M CENTRAL INDEX KEY: 0001226064 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35420 FILM NUMBER: 221145995 MAIL ADDRESS: STREET 1: 850 MAUDE AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ChemoCentryx, Inc. CENTRAL INDEX KEY: 0001340652 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943254365 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 835 INDUSTRIAL ROAD STREET 2: SUITE 600 CITY: SAN CARLOS STATE: CA ZIP: 94070 BUSINESS PHONE: 650-210-2900 MAIL ADDRESS: STREET 1: 835 INDUSTRIAL ROAD STREET 2: SUITE 600 CITY: SAN CARLOS STATE: CA ZIP: 94070 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-08-04 0 0001340652 ChemoCentryx, Inc. CCXI 0001226064 KANAYA SUSAN M C/O CHEMOCENTRYX, INC. 835 INDUSTRIAL ROAD, SUITE 600 SAN CARLOS CA 94070 1 1 0 0 EVP, CFO and Sec. Common Stock 2022-08-04 4 M 0 14583 6.23 A 105900 D Common Stock 2022-08-04 4 M 0 31715 6.62 A 137615 D Common Stock 2022-08-04 4 S 0 46298 50.1688 D 91317 D Common Stock 132717 I Kanaya Family Trust U/A Dtd 10/17/2012 Stock Option (right to buy) 6.23 2022-08-04 4 M 0 14583 D 2026-10-24 Common Stock 14583 30209 D Stock Option (right to buy) 6.62 2022-08-04 4 M 0 31715 D 2027-02-28 Common Stock 31715 76702 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $50.06 to $50.35 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. As of August 4, 2022, and prior to this transaction, the exercised options were fully vested. Not applicable. /s/ Susan M. Kanaya 2022-08-08